# Dottikon Exclusive Synthesis AG, Dottikon, Switzerland – FDA Inspections

Source: https://www.keypedia.com/companies/dottikon-exclusive-synthesis-ag/db7bdf8b-bd88-416f-94f2-62f946e90074

> Inspection records and compliance data for Dottikon Exclusive Synthesis AG in Dottikon. 4 FDA inspections on record, 1 Form 483, last inspected December 16, 2022.

---

## Details

- Name: Dottikon Exclusive Synthesis AG
- FEI Number: 3002806909
- Business Operations: API MANUFACTURE
- Address Line 1: Hembrunnstrasse 17
- City: Dottikon
- Country Name: Switzerland
- Address: Hembrunnstrasse 17, Dottikon, Switzerland
- Country: Switzerland

## Related Documents

- [483 - Dottikon Exclusive Synthesis AG - Unknown Date](https://www.keypedia.com/records/483/dottikon-exclusive-synthesis-ag/3ce85b82-9182-42c0-9f5f-fc4017e60dd5) — source: FDA, date: Invalid Date
- FDA Inspection 1194879 - Dottikon Exclusive Synthesis AG - 2022-12-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 16, 2022
- FDA Inspection 1194879 - Dottikon Exclusive Synthesis AG - 2022-12-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 16, 2022
- [FDA Inspection 1018903 - Dottikon Exclusive Synthesis AG - 2017-07-14](https://www.keypedia.com/records/fda_inspections/dottikon-exclusive-synthesis-ag/60285739-0f29-496f-8273-c76ab6c0ed69) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 14, 2017
- FDA Inspection 1018903 - Dottikon Exclusive Synthesis AG - 2017-07-14 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 14, 2017
- FDA Inspection 944297 - Dottikon Exclusive Synthesis AG - 2015-09-11 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 11, 2015
- [FDA Inspection 944297 - Dottikon Exclusive Synthesis AG - 2015-09-11](https://www.keypedia.com/records/fda_inspections/dottikon-exclusive-synthesis-ag/d32c57c5-b9af-453b-b9bb-e879452a9283) — classification: No Action Indicated (NAI), source: FDA, date: September 11, 2015
- FDA Inspection 807328 - Dottikon Exclusive Synthesis AG - 2012-09-28 — classification: No Action Indicated (NAI), source: FDA, date: September 28, 2012

## Related Companies

- [Cosma SPA](https://www.keypedia.com/companies/cosma-spa/14f96eaf-912e-4eed-af27-43ec40d9b7b7)
- [Shandong Xinhua Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-co-ltd/acea3619-5739-4a9f-a4b2-82e0207194b3)
- [Cambrex Charles City, Inc.](https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6)
- [Livzon New North River Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-new-north-river-pharmaceutical-co-ltd/49cdcdc8-9c6c-4486-b6cd-e404c21dd2d2)
- [PolyPeptide Laboratories, Inc.](https://www.keypedia.com/companies/polypeptide-laboratories-inc/9d05664c-4a42-45cc-81f6-ef85c356ecc1)
- [Novacyl](https://www.keypedia.com/companies/novacyl/928b015a-ee45-4383-ad21-070b43308727)
- [Livzon Group (Ningxia) Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-group-ningxia-pharmaceutical-co-ltd/78a1f9d4-41d0-440a-87bc-8c9521d0159a)
- [Siegfried Evionnaz SA](https://www.keypedia.com/companies/siegfried-evionnaz-sa/80827909-f3d5-4745-bc93-14f265628c39)
- [Hovione PharmaScience Limited](https://www.keypedia.com/companies/hovione-pharmascience-limited/cb368750-5a82-4f5e-b5b8-d7469313f8fd)
- [Erregierre S.p.A.](https://www.keypedia.com/companies/erregierre-spa/b911826f-b82b-46c8-a7cb-68206ff19d2e)

## Related Officers

- [Investigator ](https://www.keypedia.com/people/nicole-e-knowlton/8e65400f-249f-45fe-96fc-cb00fec6ae39)